MSWG前线把关
云顶的TauRx投资何时有成果?/前线把关
（取自云顶官网）
云顶（GENTING）投资的制药公司TauRx正在开发失智症药物，小股东权益监管机构（MSWG）询问相关投资的明细。
提问：
TauRx 正在就其口服产品氢甲硫氨酸甲磺酸盐 (HMTM) 进行监管互动和提交申请，以寻求美国、英国和其他地区的监管批准。
“投资及其他”部门调整后的 EBITDA 为负 4.849 亿令吉（年报第 132 页）
到目前为止，TauRx 的投资额是多少？HMTM 实现商业化之前还需要多少投资？
https://www.enanyang.my/名家专栏/云顶的taurx投资何时有成果前线把关
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on MSWG前线把关
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
Stock Market Enthusiast
Top 3 AI/Data Center Newsflow for the 3rd Week of December - #TENAGA, #YTL, #YTLPOWER
2
Rakuten Trade Research Reports
3
save malaysia!
4
Good Articles to Share
5
Good Articles to Share
World’s largest stablecoin issuer Tether sees US$10b in net profits for 2024
6
Good Articles to Share
Honda and Nissan consider mutual production of vehicles, Kyodo reports
7
Good Articles to Share
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
